KMT2B and lung carcinoma: H3K4me3 was most significantly downregulated in A549 and H1299 cells treated with siMLL2 rather than siMLL1 or siWDR5 (Figure 4B,C), suggesting that MLL2 could function as a core factor regulating H3K4me3 in lung cancer cells.